· 3 min read
illuminem summarises for you the essential news of the day. Read the full piece on WBCSD or enjoy below:
🗞️ Driving the news: The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical firms and supported by PwC UK, has released the sector’s first “Roadmap to Nature Positive”
• The initiative aims to help pharmaceutical companies assess and mitigate their impacts on nature across the value chain
• It aligns with the Global Biodiversity Framework’s 2030 goal to halt and reverse nature loss
🔭 The context: The roadmap was co-developed with major pharma players including GSK, AstraZeneca, Bayer, Novartis, Novo Nordisk, Reckitt and Roche
• It outlines a structured, actionable path to integrate nature-positive strategies into operations, supply chains, and product life cycles
• Phase II will focus on linking these actions with prioritised nature-related metrics and launching a digital platform for tracking progress by COP30 in November 2025
🌍 Why it matters for the planet: Nature-positive business strategies in pharma support not only biodiversity but also resilient healthcare systems and climate goals
• The sector’s value chain depends heavily on natural resources and ecosystems
• By aligning with the roadmap, companies can drive collective environmental impact while improving public health
⏭️ What's next: The roadmap encourages customisation of action plans, collaborative efforts, and adoption of standardised metrics
• A digital platform for tracking nature metrics across industries will be launched by COP30
• This will support transparency, comparability, and regulatory alignment
💬 One quote: “Nature loss and climate change present big challenges… but addressing these twin crises proactively can improve health outcomes and drive value creation.” – Will Evison, Sustainability Strategy Director, PwC UK
📈 One stat: Over 50% of global GDP is moderately or highly dependent on nature and ecosystem services, according to the World Economic Forum
See here detailed sustainability performance of companies like GSK, AstraZeneca, Bayer, Novartis, Novo Nordisk, and Roche
Click for more news covering the latest on nature and corporate sustainability
